Ekambaram Maheswari, Nabower Aleisha, Rajbhandari Prabi, Eisenberg Jaclyn, Goodrich Nathaniel, Ampofo Krow, Gollehon Nathan S, Martin Kimberly C, Lyden Elizabeth, Snowden Jessica
Department of Pediatrics, Baylor Scott and White Medical Center, Round Rock, Texas, USA.
Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska, USA.
J Pediatric Infect Dis Soc. 2022 Apr 30;11(4):134-141. doi: 10.1093/jpids/piab126.
The FilmArray Meningitis/Encephalitis panel (MEP) has an 11% false-positive and 2.2% false-negative rate compared with conventional testing. We describe clinical characteristics, treatment decisions, and outcomes in children with discordant results between MEP and conventional testing.
We conducted a multisite review of patients ≤ 18 years with suspected central nervous system infection and positive results by MEP or conventional testing (cerebrospinal fluid [CSF] culture, herpes simplex virus [HSV] polymerase chain reaction (PCR), and enterovirus [EV] PCR). Descriptive results are provided for patients with discordant results. Comparison between group 1 (MEP and CSF culture positive) and group 2 (MEP positive, CSF culture negative, or showing a different pathogen) was made by Mann-Whitney test for continuous and Fisher's test for categorical variables.
A total of 355 patients had at least one pathogen identified. More than half of patients with bacterial pathogens identified that are included in the MEP had discordant results (30/52; 58%). There were 28 samples with bacterial pathogen identified on MEP only, 1 with different bacterial pathogens on MEP and culture, and 1 with Escherichia coli identified on CSF culture only. Patients in group 1 were more likely to have CSF pleocytosis, elevated CSF protein, and decreased CSF glucose than group 2 (P < .05). Two patients were HSV positive by MEP while HSV negative by PCR. Ten patients had discordant results between MEP and EV PCR.
Discordant results between MEP and conventional testing are common. Treatment decisions based on a positive MEP should be made in the appropriate clinical context.
与传统检测方法相比,FilmArray脑膜炎/脑炎检测板(MEP)的假阳性率为11%,假阴性率为2.2%。我们描述了MEP与传统检测结果不一致的儿童的临床特征、治疗决策及预后。
我们对年龄≤18岁、疑似中枢神经系统感染且MEP或传统检测(脑脊液[CSF]培养、单纯疱疹病毒[HSV]聚合酶链反应[PCR]和肠道病毒[EV]PCR)结果为阳性的患者进行了多中心回顾性研究。对结果不一致的患者提供描述性结果。通过Mann-Whitney检验对连续变量进行组1(MEP和CSF培养均为阳性)和组2(MEP阳性、CSF培养阴性或显示不同病原体)之间的比较,通过Fisher检验对分类变量进行比较。
共有355例患者至少鉴定出一种病原体。MEP检测出的细菌病原体患者中,超过一半的结果不一致(30/52;58%)。仅在MEP上鉴定出细菌病原体的样本有28份,MEP和培养结果显示不同细菌病原体的有1份,仅在CSF培养中鉴定出大肠杆菌的有1份。与组2相比,组1患者更有可能出现CSF细胞增多、CSF蛋白升高和CSF葡萄糖降低(P <.05)。2例患者MEP检测HSV为阳性,而PCR检测为阴性。10例患者MEP与EV PCR结果不一致。
MEP与传统检测结果不一致很常见。基于MEP阳性结果的治疗决策应在适当的临床背景下做出。